BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 16402233)

  • 1. Herpes simplex virus-1 (HSV-1) infection in radiation-induced oral mucositis.
    Nicolatou-Galitis O; Athanassiadou P; Kouloulias V; Sotiropoulou-Lontou A; Dardoufas K; Polychronopoulou A; Gonidi M; Kyprianou K; Kolitsi G; Skarleas C; Pissakas G; Papanikolaou IS; Kouvaris J
    Support Care Cancer; 2006 Jul; 14(7):753-62. PubMed ID: 16402233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oral pseudomembranous candidiasis, herpes simplex virus-1 infection, and oral mucositis in head and neck cancer patients receiving radiotherapy and granulocyte-macrophage colony-stimulating factor (GM-CSF) mouthwash.
    Nicolatou-Galitis O; Dardoufas K; Markoulatos P; Sotiropoulou-Lontou A; Kyprianou K; Kolitsi G; Pissakas G; Skarleas C; Kouloulias V; Papanicolaou V; Legakis NJ; Velegraki A
    J Oral Pathol Med; 2001 Sep; 30(8):471-80. PubMed ID: 11545238
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy of valacyclovir in preventing recurrent herpes simplex virus infections associated with dental procedures.
    Miller CS; Cunningham LL; Lindroth JE; Avdiushko SA
    J Am Dent Assoc; 2004 Sep; 135(9):1311-8. PubMed ID: 15493396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical utility of oral valacyclovir compared with oral acyclovir for the prevention of herpes simplex virus mucositis following autologous bone marrow transplantation or stem cell rescue therapy.
    Eisen D; Essell J; Broun ER; Sigmund D; DeVoe M
    Bone Marrow Transplant; 2003 Jan; 31(1):51-5. PubMed ID: 12621507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Valacyclovir prophylaxis for the prevention of Herpes simplex virus reactivation in recipients of progenitor cells transplantation.
    Dignani MC; Mykietiuk A; Michelet M; Intile D; Mammana L; Desmery P; Milone G; Pavlovsky S
    Bone Marrow Transplant; 2002 Feb; 29(3):263-7. PubMed ID: 11859400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Valacyclovir and acyclovir for suppression of shedding of herpes simplex virus in the genital tract.
    Gupta R; Wald A; Krantz E; Selke S; Warren T; Vargas-Cortes M; Miller G; Corey L
    J Infect Dis; 2004 Oct; 190(8):1374-81. PubMed ID: 15378428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Valacyclovir for herpes simplex virus infection: long-term safety and sustained efficacy after 20 years' experience with acyclovir.
    Tyring SK; Baker D; Snowden W
    J Infect Dis; 2002 Oct; 186 Suppl 1():S40-6. PubMed ID: 12353186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Herpes simplex virus infection.
    Whitley RJ
    Semin Pediatr Infect Dis; 2002 Jan; 13(1):6-11. PubMed ID: 12118847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Valacyclovir prophylaxis for herpes simplex virus infection or infection recurrence following laser skin resurfacing.
    Beeson WH; Rachel JD
    Dermatol Surg; 2002 Apr; 28(4):331-6. PubMed ID: 11966791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term valacyclovir suppressive treatment after herpes simplex virus type 2 meningitis: a double-blind, randomized controlled trial.
    Aurelius E; Franzen-Röhl E; Glimåker M; Akre O; Grillner L; Jorup-Rönström C; Studahl M;
    Clin Infect Dis; 2012 May; 54(9):1304-13. PubMed ID: 22460966
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herpes simplex virus (HSV) suppression with valacyclovir reduces rectal and blood plasma HIV-1 levels in HIV-1/HSV-2-seropositive men: a randomized, double-blind, placebo-controlled crossover trial.
    Zuckerman RA; Lucchetti A; Whittington WL; Sanchez J; Coombs RW; Zuñiga R; Magaret AS; Wald A; Corey L; Celum C
    J Infect Dis; 2007 Nov; 196(10):1500-8. PubMed ID: 18008230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Herpes simplex virus 2 meningitis: a retrospective cohort study.
    Miller S; Mateen FJ; Aksamit AJ
    J Neurovirol; 2013 Apr; 19(2):166-71. PubMed ID: 23494382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of valacyclovir on viral shedding in immunocompetent patients with recurrent herpes simplex virus 2 genital herpes: a US-based randomized, double-blind, placebo-controlled clinical trial.
    Fife KH; Warren TJ; Ferrera RD; Young DG; Justus SE; Heitman CK; Burroughs SM
    Mayo Clin Proc; 2006 Oct; 81(10):1321-7. PubMed ID: 17036557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral valacyclovir versus intravenous acyclovir in preventing herpes simplex virus infections in autologous stem cell transplant recipients.
    Liesveld JL; Abboud CN; Ifthikharuddin JJ; Lancet JE; Wedow LA; Oliva J; Stamm CG; Nichols D
    Biol Blood Marrow Transplant; 2002; 8(12):662-5. PubMed ID: 12523578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An international, randomized, double-blind, placebo-controlled, study of valacyclovir for the suppression of herpes simplex virus type 2 genital herpes in newly diagnosed patients.
    Fife KH; Warren TJ; Justus SE; Heitman CK;
    Sex Transm Dis; 2008 Jul; 35(7):668-73. PubMed ID: 18461016
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interventions for the prevention and treatment of herpes simplex virus in patients being treated for cancer.
    Glenny AM; Fernandez Mauleffinch LM; Pavitt S; Walsh T
    Cochrane Database Syst Rev; 2009 Jan; (1):CD006706. PubMed ID: 19160295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Successful treatment of generalized primary herpes simplex type 2 infection during pregnancy.
    Anderson R; Lundqvist A; Bergström T
    Scand J Infect Dis; 1999; 31(2):201-2. PubMed ID: 10447333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroprevalence of HSV-1/2 and correlation with aggravation of oral mucositis in patients with squamous cell carcinoma of the head and neck region submitted to antineoplastic treatment.
    Correia AV; Coêlho MR; de Oliveira Mendes Cahú GG; de Almeida Silva JL; da Mota Vasconcelos Brasil C; de Castro JF
    Support Care Cancer; 2015 Jul; 23(7):2105-11. PubMed ID: 25547479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical features of atypical presentations of mucocutaneous herpes simplex virus infection observed in immunosuppressed individuals. Part II: the knife-cut sign.
    Cohen PR
    Dermatol Online J; 2024 Mar; 30(1):. PubMed ID: 38762853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of famciclovir and valacyclovir on herpes simplex virus type 1 infection, latency, and reactivation in mice: how dissimilar are study results?
    Thackray AM; Field HJ
    J Infect Dis; 2000 Apr; 181(4):1517-8. PubMed ID: 10762588
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.